Medistep Healthcare IPO: GMP, Price, Allotment & In-Depth Review
07 August 2025 · Sachin Gadekar
Medistep Healthcare IPO opens on August 8: GMP, price, allotment, and full review.
Introduction
Ultra brings you a complete breakdown of the Medistep Healthcare IPO, a fixed price SME issue gaining investor attention. In this article, we cover everything — from Medistep Healthcare IPO GMP today to IPO dates, financials, company review, and key highlights — to help you decide whether to invest.
Medistep Healthcare IPO Details
| Particulars | Details |
|---|---|
| IPO Open Date | August 8, 2025 |
| IPO Close Date | August 12, 2025 |
| IPO Price | ₹43 per share |
| Lot Size | 3,000 Shares |
| Minimum Investment (Retail) | ₹2,58,000 (6,000 shares) |
| Listing Platform | NSE SME |
| Issue Size | ₹16.10 Crores (Fresh Issue) |
| Tentative Listing Date | August 18, 2025 |
Medistep Healthcare IPO Timeline
| Event | Date |
|---|---|
| IPO Open Date | August 8, 2025 |
| IPO Close Date | August 12, 2025 |
| Allotment Finalization | August 13, 2025 |
| Refund Initiation | August 14, 2025 |
| Credit of Shares | August 14, 2025 |
| Listing Date | August 18, 2025 |
Medistep Healthcare IPO Lot Size & Investment
| Investor Type | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min & Max) | 2 | 6,000 | ₹2,58,000 |
| HNI (Min) | 3 | 9,000 | ₹3,87,000 |
Medistep Healthcare IPO Reservation Structure
| Investor Category | Shares Offered | Percentage |
|---|---|---|
| Market Maker | 1,89,000 | 5.05% |
| Retail Individual Investors (RII) | 17,79,000 | 47.52% |
| Non-Institutional Investors (NII) | 17,76,000 | 47.44% |
About Medistep Healthcare Ltd
Incorporated in June 2023, Medistep Healthcare Limited is a fast-growing pharmaceutical and healthcare company. It manufactures and trades a variety of products across pharmaceutical, nutraceutical, feminine hygiene, intimate care, and surgical segments.
Key Products:
Sanitary Pads (DRYSTEP) – Essential feminine hygiene products
Energy Powders (VITASTEP Z) – Nutraceutical supplement for energy and stamina
Pharmaceutical Products – Trading of essential medications
Nutraceuticals – Wellness supplements combining nutrition and medicine
Intimate Hygiene – Personal care for women
Surgical Items – Medical-use surgical products
The company operates with a lean team of nine employees (as of December 2024) and relies on daily-paid labor for manufacturing flexibility.
Competitive Strengths
Diverse Product Line: Offering pharmaceutical, nutritional, and hygiene-based products
Experienced Management: Promoters bring operational and strategic expertise
Cost Efficiency: Economies of scale due to versatile manufacturing
Growing Market Demand: Taps into rapidly expanding wellness and hygiene segments
Medistep Healthcare Ltd Financials
| Metric | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Total Income | 49.66 | 39.08 | 27.74 |
| Profit After Tax (PAT) | 4.14 | 3.33 | 0.92 |
| EBITDA | 5.60 | 4.54 | 1.34 |
| Net Worth | 16.83 | 11.69 | 1.07 |
Medistep Healthcare IPO GMP Today
The Medistep Healthcare IPO GMP (Grey Market Premium) is currently under observation. Early indications suggest moderate interest, driven by its strong product diversification and growing revenue. However, as always with SME IPOs, investors should track GMP trends closer to the listing date.
Medistep Healthcare IPO Review
Positives:
Strong growth in revenue and profitability
Diversified product offerings in essential healthcare segments
Lean operational model with scope for scalability
Low debt and increasing net worth
Risks:
High entry barrier for retail investors (₹2.58 lakh minimum investment)
Dependence on third-party labor may pose long-term operational challenges
SME IPOs may see lower post-listing liquidity
Verdict:
The Medistep Healthcare IPO offers an opportunity to invest in a company operating in essential and high-demand sectors like hygiene and health supplements. With steady financial growth and product relevance, this IPO could appeal to HNIs and experienced retail investors. However, as with any SME IPO, proceed with caution and evaluate based on your risk appetite.
FAQs on Medistep Healthcare IPO
1. What is the Medistep Healthcare IPO GMP today?
As of now, the GMP is not firmly established. You should track reliable IPO platforms for daily updates closer to listing.
2. What is the price and lot size of Medistep Healthcare IPO?
The IPO is priced at ₹43 per share with a lot size of 3,000 shares. Minimum application requires 6,000 shares (2 lots), amounting to ₹2,58,000.
3. When will Medistep Healthcare IPO allotment be finalized?
The allotment is expected to be finalized on August 13, 2025.
4. Where will Medistep Healthcare IPO be listed?
It will be listed on the NSE SME platform on August 18, 2025.
5. Is Medistep Healthcare Ltd a profitable company?
Yes, the company has posted consistent growth in income and profit since FY23.
6. Is Medistep Healthcare IPO good for long-term investment?
While the company operates in a promising segment, investors must assess risk factors, GMP movement, and listing performance before committing to a long-term investment.
Final Thoughts
The Medistep Healthcare Ltd IPO presents a promising opportunity in India’s expanding healthcare and wellness space. Backed by rising revenues, product diversity, and a lean business model, it stands as an attractive proposition, especially for investors looking at SME IPOs. As always, it’s advisable to do your due diligence and track market signals like GMP before making your investment decision.
For more IPO updates, expert reviews, and insights into alternative investments, stay tuned with Ultra.